Search research articles
Contact Us
Filters
Showing results (441-450 of 505) with videos related to
Page
of 51
Sort By:
Cancer Research
|
July 15, 1994
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
R Umbas, W B Isaacs, P P Bringuier, et al.
European Urology
|
January 1, 1995
Automated analysis and interpretation of transrectal ultrasonography images in patients with prostatitis
J J de la Rosette, R J Giesen, A L Huynen, et al.
European Urology
|
January 1, 1997
The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment
A F Bierkens, A J Hendrikx, K E Ezz el Din, et al.
The Journal of Urology
|
June 17, 1998
Multifocal transitional cell cancer and p53 mutation analysis
H G Van Der Poel, D Hessels, G J Van Leenders, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Phase I/II study of recombinant interferon alpha and gamma in advanced progressive renal-cell carcinoma
P H de Mulder, F M Debruyne, M P Franssen, et al.
Cancer Research
|
September 15, 1992
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
R Umbas, J A Schalken, T W Aalders, et al.
European Urology
|
January 1, 1987
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma
K H Kurth, F M Debruyne, R R Hall, et al.
Journal of Endourology
|
July 11, 1998
Influence of decay of laser fibers during laser prostatectomy on clinical results
E te Slaa, C F van Swol, T A Boon, et al.
Urology
|
February 5, 1999
Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification
F C D'Ancona, A K van der Bij, E A Francisca, et al.
The Journal of Urology
|
January 1, 1994
Antitumoral effects of liarozole in androgen-dependent and independent R3327-Dunning prostate adenocarcinomas
G A Dijkman, R J Van Moorselaar, R Van Ginckel, et al.
Page
of 51
Search research articles
Search
Showing results (441-450 of 505) with videos related to
Sort By:
Page
of 51
Cancer Research
|
July 15, 1994
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
R Umbas, W B Isaacs, P P Bringuier, et al.
European Urology
|
January 1, 1995
Automated analysis and interpretation of transrectal ultrasonography images in patients with prostatitis
J J de la Rosette, R J Giesen, A L Huynen, et al.
European Urology
|
January 1, 1997
The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment
A F Bierkens, A J Hendrikx, K E Ezz el Din, et al.
The Journal of Urology
|
June 17, 1998
Multifocal transitional cell cancer and p53 mutation analysis
H G Van Der Poel, D Hessels, G J Van Leenders, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Phase I/II study of recombinant interferon alpha and gamma in advanced progressive renal-cell carcinoma
P H de Mulder, F M Debruyne, M P Franssen, et al.
Cancer Research
|
September 15, 1992
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
R Umbas, J A Schalken, T W Aalders, et al.
European Urology
|
January 1, 1987
Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma
K H Kurth, F M Debruyne, R R Hall, et al.
Journal of Endourology
|
July 11, 1998
Influence of decay of laser fibers during laser prostatectomy on clinical results
E te Slaa, C F van Swol, T A Boon, et al.
Urology
|
February 5, 1999
Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification
F C D'Ancona, A K van der Bij, E A Francisca, et al.
The Journal of Urology
|
January 1, 1994
Antitumoral effects of liarozole in androgen-dependent and independent R3327-Dunning prostate adenocarcinomas
G A Dijkman, R J Van Moorselaar, R Van Ginckel, et al.
Page
of 51